The story discusses the potential impact of AI in cancer research, with opinions divided on whether AI can replace human scientists in the field. Italian pharma company Recordati is buying rights to a drug for a rare autoimmune disorder from Sanofi. Chinese drugmakers WuXi AppTec and WuXi Biologics are selling some operations due to the BIOSECURE Act in the US. A new study sheds light on auditory hallucinations in schizophrenia. President Biden’s health care AI czar, Micky Tripathi, is discussed in the latest episode of “The Readout LOUD” podcast. Gilead is donating remdesivir for emergency use against Marburg disease in Rwanda. Opdivo receives FDA approval for use around lung cancer surgery.
Source link
Sanofi, WuXi, OpenAI, Gilead news
